Hexanoyl-Lysine adduct BSA Conjugate

Hexanoyl-Lysine Adduct (HEL) BSA Conjugate is a lipid peroxidation biomarker used to detect early oxidative stress in neural tissues. HEL forms when omega-6 polyunsaturated fatty acids undergo peroxidation, generating reactive aldehydes that covalently modify lysine residues on proteins. In neurodegenerative diseases such as multiple sclerosis and Alzheimer’s, HEL levels are elevated in serum and brain tissue, reflecting increased oxidative damage and ferroptosis. HEL-BSA conjugates are used in ELISA and immunohistochemistry to quantify oxidative stress and monitor disease progression. This conjugate is a valuable tool for identifying redox imbalances and evaluating antioxidant therapies in models of neuroinflammation and neurodegeneration.

Hexanoyl-Lysine adduct BSA Conjugate, Hexanoyl-Lysine adduct-BSA Conjugate, Hexanoyl-Lysine adduct (BSA) Conjugate, HEL (Hexanoyl-Lysine adduct) BSA Conjugate, HEL BSA Conjugate, Hexanoyl-Lys adduct BSA Conjugate, Hexanoyl-Lys BSA Conjugate, Hexanoyl-Lysine (HEL) adduct BSA Conjugate, Hexanoyl-Lys (HEL) BSA Conjugate, Hexanoyl-Lysine adduct Bovine Serum Albumin Conjugate, Hexanoyl-Lysine adduct-Bovine Serum Albumin Conjugate, Hexanoyl-Lysine adduct (Bovine Serum Albumin) Conjugate, HEL (Hexanoyl-Lysine adduct) Bovine Serum Albumin Conjugate, Hexanoyl-Lys adduct Bovine Serum Albumin Conjugate, Hexanoyl-Lys Bovine Serum Albumin Conjugate, Bovine Serum Albumin conjugated with Hexanoyl-Lysine adduct, Hexanoyl-Lysine adduct-modified BSA